Position in RDNT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$70,527,168
+$40,040,627 QoQ
Shares Held
1,143,622
+109.7% QoQ
Ownership
1.45%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#20
of 328 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Penserra Capital Management LLC holds $74,548,818 across 15 Diagnostics & Research names. RDNT ranks #1 (94.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDNT |
RadNet, Inc.
This page
|
1,143,622 | $70,527,168 | |
| 2 | GH |
Guardant Health, Inc.
|
19,575 | $2,936,837 | |
| 3 | NTRA |
Natera, Inc.
|
2,504 | $679,710 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
990 | $188,391 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
119 | $148,194 | |
| 6 | RVTY |
Revvity, Inc.
|
326 | $36,270 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
30 | $15,040 | |
| 8 | DHR |
Danaher Corp /De/
|
57 | $10,857 |
All Filings in RDNT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,527,168 | 1,143,622 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $30,486,541 | 545,474 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $36,946,599 | 517,822 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $36,510,458 | 479,077 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $19,018,183 | 334,180 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $10,088,237 | 202,901 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $10,048,788 | 143,883 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,697,286 | 67,694 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,035,371 | 68,489 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||